Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. It also provides food and technical grade purified phosphoric acid (PPA) used in the production of phosphate salts, as well as in food and beverages, and water treatment applications; technical grade sodium tripolyphosphate (STPP), a specialty phosphate, which is used as an ingredient in cleaning products, such as industrial and institutional cleaners, automatic dishwashing detergents, and consumer laundry detergents, as well as in water treatment, clay processing, and copper ore processing activities; and detergent grade PPA that is primarily used in the production of STPP. In addition, the company offers granular triple super-phosphate (GTSP), a fertilizer product line used for enhancing crop yields in various agricultural sectors; and merchant green phosphoric acid. It serves primarily consumer goods manufacturers, distributors, and specialty chemical manufacturers in the United States, Canada, Mexico, and internationally. Innophos Holdings, Inc. was founded in 2004 and is headquartered in Cranbury, New Jersey.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IPHS
Previous Symbol
CUSIP45774N10
Phone609-495-2495
Debt
Debt-to-Equity Ratio1.01
Current Ratio2.79
Quick Ratio1.36
Price-To-Earnings
Trailing P/E Ratio10.04
Forward P/E Ratio10.97
P/E GrowthN/A
Sales & Book Value
Annual Sales$722.02 million
Price / Sales0.67
Cash Flow$4.5807 per share
Price / Cash Flow5.39
Book Value$17.08 per share
Price / Book1.45
Profitability
EPS (Most Recent Fiscal Year)$2.46
Net Income$22.44 million
Net Margins2.49%
Return on Equity13.30%
Return on Assets5.56%
Miscellaneous
Employees1,373
Outstanding Shares19,620,000
Market Cap$484.32 million
OptionableOptionable
Innophos (NASDAQ:IPHS) Frequently Asked Questions
What is Innophos' stock symbol?
Innophos trades on the NASDAQ under the ticker symbol "IPHS."
How often does Innophos pay dividends? What is the dividend yield for Innophos?
Innophos announced a quarterly dividend on Friday, November 2nd. Stockholders of record on Friday, November 16th will be given a dividend of $0.48 per share on Friday, December 7th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 7.78%. The ex-dividend date is Thursday, November 15th. View Innophos' Dividend History.
How were Innophos' earnings last quarter?
Innophos Holdings, Inc. (NASDAQ:IPHS) released its quarterly earnings data on Thursday, November, 1st. The specialty chemicals company reported $0.58 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.59 by $0.01. The specialty chemicals company had revenue of $196.93 million for the quarter, compared to the consensus estimate of $197.20 million. Innophos had a return on equity of 13.30% and a net margin of 2.49%. The business's revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.78 earnings per share. View Innophos' Earnings History.
When is Innophos' next earnings date?
What guidance has Innophos issued on next quarter's earnings?
Innophos issued an update on its FY 2018 earnings guidance on Thursday, November, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $791-806 million, compared to the consensus revenue estimate of $801.6 million.Innophos also updated its guidance to EPS.
Has Innophos been receiving favorable news coverage?
News stories about IPHS stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Innophos earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term.
Who are some of Innophos' key competitors?
Who are Innophos' key executives?
Innophos' management team includes the folowing people:
- Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 58)
- Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 52)
- Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 50)
- Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 41)
- Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 42)
Who are Innophos' major shareholders?
Innophos' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.27%), Vanguard Group Inc. (10.53%), Dimensional Fund Advisors LP (5.33%), Frontier Capital Management Co. LLC (4.51%), Renaissance Technologies LLC (3.77%) and American Century Companies Inc. (3.70%). View Institutional Ownership Trends for Innophos.
Which major investors are selling Innophos stock?
IPHS stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Prudential Financial Inc., JPMorgan Chase & Co., JPMorgan Chase & Co., TIAA CREF Investment Management LLC, AXA, PNC Financial Services Group Inc. and Renaissance Technologies LLC. View Insider Buying and Selling for Innophos.
Which major investors are buying Innophos stock?
IPHS stock was bought by a variety of institutional investors in the last quarter, including Northpointe Capital LLC, BlackRock Inc., American Century Companies Inc., Frontier Capital Management Co. LLC, Vanguard Group Inc., Wells Fargo & Company MN, Morgan Stanley and Dalton Greiner Hartman Maher & Co.. View Insider Buying and Selling for Innophos.
How do I buy shares of Innophos?
Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innophos' stock price today?
One share of IPHS stock can currently be purchased for approximately $24.69.
How big of a company is Innophos?
Innophos has a market capitalization of $484.32 million and generates $722.02 million in revenue each year. The specialty chemicals company earns $22.44 million in net income (profit) each year or $2.46 on an earnings per share basis. Innophos employs 1,373 workers across the globe.
What is Innophos' official website?
How can I contact Innophos?
Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]
MarketBeat Community Rating for Innophos (NASDAQ IPHS)
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
